ReproCELL Incorporated (4978.T)

JPY 103.0

(0.0%)

Total Debt Summary of ReproCELL Incorporated

  • ReproCELL Incorporated's latest annual total debt in 2023 was - JPY , down 0.0% from previous year.
  • ReproCELL Incorporated's latest quarterly total debt in 2024 Q1 was - JPY , down 0.0% from previous quarter.
  • ReproCELL Incorporated reported annual total debt of - JPY in 2022, down -100.0% from previous year.
  • ReproCELL Incorporated reported annual total debt of 80 Million JPY in 2021, down 0.0% from previous year.
  • ReproCELL Incorporated reported quarterly total debt of - JPY for 2023 Q3, down 0.0% from previous quarter.
  • ReproCELL Incorporated reported quarterly total debt of - JPY for 2023 Q4, down 0.0% from previous quarter.

Annual Total Debt Chart of ReproCELL Incorporated (2023 - 2011)

Historical Annual Total Debt of ReproCELL Incorporated (2023 - 2011)

Year Total Debt Total Debt Growth
2023 - JPY 0.0%
2022 - JPY -100.0%
2021 80 Million JPY 0.0%
2020 80 Million JPY 0.0%
2019 80 Million JPY 0.0%
2018 80 Million JPY -3.01%
2017 82.48 Million JPY -3.71%
2016 85.65 Million JPY -6.31%
2015 91.42 Million JPY 14.28%
2014 80 Million JPY 0.0%
2013 80 Million JPY 0.0%
2012 80 Million JPY 0.0%
2011 - JPY 0.0%

Peer Total Debt Comparison of ReproCELL Incorporated

Name Total Debt Total Debt Difference
KOHJIN BIO CO LTD 2.46 Billion JPY 100.0%
PRISM BioLab Co.,LTD - JPY NaN%
GNI Group Ltd. 3.69 Billion JPY 100.0%
Linical Co., Ltd. 3 Billion JPY 100.0%
Trans Genic Inc. 2.25 Billion JPY 100.0%
MEDINET Co., Ltd. 2.3 Million JPY 100.0%
Soiken Holdings Inc. - JPY NaN%
Cytori Cell Research Institute, Inc. 2.47 Billion JPY 100.0%
AnGes, Inc. 362.67 Million JPY 100.0%
OncoTherapy Science, Inc. 106.84 Million JPY 100.0%
Nxera Pharma Co., Ltd. 73.97 Billion JPY 100.0%
Immuno-Biological Laboratories Co., Ltd. 235.98 Million JPY 100.0%
NanoCarrier Co., Ltd. 1.1 Billion JPY 100.0%
Carna Biosciences, Inc. 182.97 Million JPY 100.0%
CanBas Co., Ltd. - JPY NaN%
D. Western Therapeutics Institute, Inc. 885.12 Million JPY 100.0%
RaQualia Pharma Inc. 367.71 Million JPY 100.0%
Chiome Bioscience Inc. 291 Million JPY 100.0%
Kidswell Bio Corporation 2.57 Billion JPY 100.0%
PeptiDream Inc. 22.79 Billion JPY 100.0%
Oncolys BioPharma Inc. 315.17 Million JPY 100.0%
Ribomic Inc. - JPY NaN%
SanBio Company Limited 665 Million JPY 100.0%
Healios K.K. 4.53 Billion JPY 100.0%
BrightPath Biotherapeutics Co., Ltd. 112.5 Million JPY 100.0%
Kubota Pharmaceutical Holdings Co., Ltd. 142.85 Million JPY 100.0%
Delta-Fly Pharma, Inc. - JPY NaN%
StemRIM - JPY NaN%
CellSource Co., Ltd. 97.54 Million JPY 100.0%
FunPep Company Limited - JPY NaN%
Kringle Pharma, Inc. - JPY NaN%
Stella Pharma Corporation 933.3 Million JPY 100.0%
TMS Co., Ltd. - JPY NaN%
Noile-Immune Biotech Inc. - JPY NaN%
Cuorips Inc. - JPY NaN%
K Pharma,Inc. - JPY NaN%
Takara Bio Inc. 968 Million JPY 100.0%
PhoenixBio Co., Ltd. 723.93 Million JPY 100.0%
StemCell Institute Inc. 8.78 Million JPY 100.0%
Japan Tissue Engineering Co., Ltd. - JPY NaN%
CellSeed Inc. 151.25 Million JPY 100.0%